REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Fresenius Kabi Indonesia (Indonesia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: PT Fresenius Kabi Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Fresenius Kabi Indonesia is a company based in Indonesia, with its head office in South Jakarta. The enterprise currently operates in the Medicinal and Botanical Manufacturing sector. The enterprise was incorporated on 2006. There was a net sales revenue increase of 19.68% reported in PT Fresenius Kabi Indonesia’s latest financial highlights for 2022. Its’ total assets recorded a growth of 19.04%.

Headquarters
Kav 71-73
South Jakarta; Jakarta; Postal Code: 12870

Contact Details: Purchase the PT Fresenius Kabi Indonesia report to view the information.

Website: http://www.fresenius-kabi.com

Basic Information
Outstanding Shares:
Purchase the PT Fresenius Kabi Indonesia report to view the information.
Registered Capital:
Purchase the PT Fresenius Kabi Indonesia report to view the information.
Incorporation Date:
2006
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Others
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Fresenius Kabi Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
19.68%
Total operating revenue
19.68%
Total assets
19.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?